MDSO
Medidata Solutions Inc
Medidata Solutions Inc historical holders
total: 2
Polen Capital Management Medidata Solutions Inc transactions over time
- Total transactions:
- 10
- New positions:
- 1
- Sold out:
- 1
- Added:
- 7
- Reduced:
- 1
- Held since:
- 2017 Q3
- Held for:
- 9 quarters
- Latest activity:
- 2019 Q4
Polen Capital Management has been an institutional investor in Medidata Solutions Inc (MDSO) since 2017 Q3. According to 2026 Q2 report, Polen Capital Management doesn't hold any shares. The fund/company first acquired MDSO in 2017 Q3, initially purchasing 2,622 shares. Since the initial investment, Polen Capital Management has made 9 more transactions in this position.
When did Polen Capital Management exit their MDSO position?
Polen Capital Management no longer holds Medidata Solutions Inc (MDSO). They sold off their entire position in 2019 Q4, closing out an investment that began in 2017 Q3.
When did Polen Capital Management first invest in MDSO?
Polen Capital Management first invested in Medidata Solutions Inc (MDSO) in 2017 Q3 at the reported quarter-end price of $78.18 per share, acquiring 2,622 shares in their initial purchase.
What is Polen Capital Management's average cost basis for MDSO?
Based on historical transaction data, Polen Capital Management's estimated cost basis for Medidata Solutions Inc (MDSO) is approximately $73.31 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $73.31
- Weighted AVG sell price:
- $67.92
MDSO transactions history by Polen Capital Management
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$91.53
|
-100% (-13,864)
|
|||
|
2019 Q3
|
0.01%
|
$91.53
|
+1.01% (+138)
|
|||
|
2019 Q2
|
0.01%
|
$90.49
|
+8.12% (+1,031)
|
|||
|
2019 Q1
|
0.00%
|
$73.26
|
+8.42% (+986)
|
|||
|
2018 Q4
|
0.01%
|
$67.38
|
-98.10% (-604,943)
|
|||
|
2018 Q3
|
0.26%
|
$73.31
|
+8,218.52% (+609,239)
|
|||
|
2018 Q2
|
0.00%
|
$80.53
|
+12.20% (+806)
|
|||
|
2018 Q1
|
0.00%
|
$62.81
|
+42.39% (+1,967)
|
|||
|
2017 Q4
|
0.00%
|
$63.36
|
+76.96% (+2,018)
|
|||
|
2017 Q3
|
0.00%
|
$78.18
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.